Neoadjuvant Triple Therapy for Resectable HCC

Clinical trial NCT06569498 · RECRUITING

Trial details

NCT number: NCT06569498
Sponsor: Fujian Provincial Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Resectable Hepatocellular Carcinoma

Start date: 2024-09-30
Primary completion: 2026-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.